Trial Profile
A randomized, controlled, double-blind, double-dummy clinical trial to evaluate the safety and efficacy of Loxoprofen Sodium Cataplasm ointment (Loxonin;PAP100mg) against myalgia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Feb 2019
Price :
$35
*
At a glance
- Drugs Loxoprofen (Primary) ; Loxoprofen
- Indications Muscle pain
- Focus Therapeutic Use
- Acronyms SELSOAM
- Sponsors Lead Chemical
- 06 Feb 2019 Results published in the Clinical Drug Investigation Journal.
- 12 Feb 2015 New trial record